149 related articles for article (PubMed ID: 29579732)
1. Development, validation and utilization of a highly sensitive LC-MS/MS method for quantification of levonorgestrel released from a subdermal implant in human plasma.
Cirrincione LR; Penchala SD; Scarsi KK; Podany AT; Winchester LC; Back DJ; Khoo SH; Fletcher CV; Siccardi M; Else LJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1084():106-112. PubMed ID: 29579732
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of sensitive LC/MS/MS method for quantitative bioanalysis of levonorgestrel in rat plasma and application to pharmacokinetics study.
Ananthula S; Janagam DR; Jamalapuram S; Johnson JR; Mandrell TD; Lowe TL
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1003():47-53. PubMed ID: 26409262
[TBL] [Abstract][Full Text] [Related]
3. Determination of levonorgestrel in human plasma by liquid chromatography-tandem mass spectrometry method: application to a bioequivalence study of two formulations in healthy volunteers.
Zhao LZ; Zhong GP; Bi HC; Ding L; Deng Y; Guan S; Chen X; Huang ZY; Huang M
Biomed Chromatogr; 2008 May; 22(5):519-26. PubMed ID: 18254150
[TBL] [Abstract][Full Text] [Related]
4. Quantitative determination of levonorgestrel in beagle dog plasma after vaginal administration of intravaginal ring by high-performance liquid chromatography-tandem mass spectrometry.
Liu Z; Qiu S; Gu Y; Ning M
Biomed Chromatogr; 2018 Dec; 32(12):e4367. PubMed ID: 30120779
[TBL] [Abstract][Full Text] [Related]
5. An Integrated Population Pharmacokinetic Analysis to Characterize Levonorgestrel Pharmacokinetics After Different Administration Routes.
Reinecke I; Hofmann B; Mesic E; Drenth HJ; Garmann D
J Clin Pharmacol; 2018 Dec; 58(12):1639-1654. PubMed ID: 30207604
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of levonorgestrel and two endogenous sex hormones in human plasma based on LC-MS/MS.
Wang R; Tian Y; Zhang L; Zhang Z
Bioanalysis; 2016 Jun; 8(11):1133-44. PubMed ID: 27211854
[TBL] [Abstract][Full Text] [Related]
7. First week drug concentrations in women with levonorgestrel rod or Norplant capsule implants.
Sivin I; Lähteenmäki P; Mishell DR; Alvarez F; Diaz S; Ranta S; Grozinger C; Lacarra M; Brache V; Pavez M; Nash H; Stern J
Contraception; 1997 Nov; 56(5):317-21. PubMed ID: 9437561
[TBL] [Abstract][Full Text] [Related]
8. Selective and sensitive liquid chromatography-tandem mass spectrometry method for the determination of levonorgestrel in human plasma.
Theron HB; Coetzee C; Sutherland FC; Wiesner JL; Swart KJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):331-6. PubMed ID: 15556549
[TBL] [Abstract][Full Text] [Related]
9. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.
Ali M; Akin A; Bahamondes L; Brache V; Habib N; Landoulsi S; Hubacher D;
Hum Reprod; 2016 Nov; 31(11):2491-2498. PubMed ID: 27671673
[TBL] [Abstract][Full Text] [Related]
10. Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks.
Scarsi KK; Darin KM; Nakalema S; Back DJ; Byakika-Kibwika P; Else LJ; Dilly Penchala S; Buzibye A; Cohn SE; Merry C; Lamorde M
Clin Infect Dis; 2016 Mar; 62(6):675-682. PubMed ID: 26646680
[TBL] [Abstract][Full Text] [Related]
11. Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: The DoubLNG pharmacokinetic study.
Cirrincione LR; Nakalema S; Chappell CA; Byakika-Kibwika P; Kyohairwe I; Winchester L; Mackline H; Pham MM; Cohn SE; Siccardi M; Owen A; Fletcher CV; Lamorde M; Scarsi KK
Contraception; 2023 Jun; 122():109975. PubMed ID: 36787829
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a multiplexed assay for the measurement of long-acting hormonal contraceptives in plasma via liquid chromatography-tandem mass spectrometry.
Knezevic CE; Parsons TL; Gollings R; Pandey A; Marzinke MA
J Pharm Biomed Anal; 2023 May; 228():115321. PubMed ID: 36924631
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetic analysis of levonorgestrel-releasing intrauterine systems and levonorgestrel-containing contraceptives with oral or subdermal administration route.
Hofmann BM; Apter D; Bitzer J; Reinecke I; Serrani M; Höchel J; Merz M
Eur J Contracept Reprod Health Care; 2020 Dec; 25(6):417-426. PubMed ID: 33006493
[TBL] [Abstract][Full Text] [Related]
14. Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system.
Seeber B; Ziehr SC; Gschlieβer A; Moser C; Mattle V; Seger C; Griesmacher A; Concin N; Concin H; Wildt L
Contraception; 2012 Oct; 86(4):345-9. PubMed ID: 22402256
[TBL] [Abstract][Full Text] [Related]
15. RP-HPLC method validation for fast extraction and quantification of Levonorgestrel drug from silicone based intrauterine device intended for in-process and finished formulation.
Veeran MG; C K; B B; Painuly D; Aprem AS
Daru; 2021 Jun; 29(1):185-193. PubMed ID: 33934266
[TBL] [Abstract][Full Text] [Related]
16. Comparative assessment of the effects of subdermal levonorgestrel implant system and long acting progestogen injection method on lipid metabolism.
Anwar M; Soejono SK; Maruo T; Abdullah N
Asia Oceania J Obstet Gynaecol; 1994 Mar; 20(1):53-8. PubMed ID: 8172528
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of two low-dose levonorgestrel-releasing intrauterine systems and effects on ovulation rate and cervical function: pooled analyses of phase II and III studies.
Apter D; Gemzell-Danielsson K; Hauck B; Rosen K; Zurth C
Fertil Steril; 2014 Jun; 101(6):1656-62.e1-4. PubMed ID: 24726226
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
Kuhnz W; Staks T; Jütting G
Contraception; 1994 Dec; 50(6):563-79. PubMed ID: 7705098
[TBL] [Abstract][Full Text] [Related]
19. A sensitive LC-MS/MS-based bioanalytical method for quantification of salviaflaside and rosmarinic acid in rat plasma and its application in a pharmacokinetic study.
Yang Y; Ying S; Li T; Zhen J; Chen D; Wang J
Biomed Chromatogr; 2018 Aug; 32(8):e4259. PubMed ID: 29655233
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of mifepristone and monodemethyl-mifepristone in human plasma by liquid chromatography-tandem mass spectrometry method using levonorgestrel as an internal standard: application to a pharmacokinetic study.
Tang C; Bi HC; Zhong GP; Chen X; Huang ZY; Huang M
Biomed Chromatogr; 2009 Jan; 23(1):71-80. PubMed ID: 18816505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
